This page lists the SEC filings reported by Prospect Venture Partners III L P.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2016-01-26 | Prospect Venture Partners III L P | KYTHERA BIOPHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2014-02-10 | Prospect Venture Partners III L P | KYTHERA BIOPHARMACEUTICALS INC | 1,914,566 | 8.9% | EDGAR |
| SC 13G/A | 2014-02-10 | Prospect Venture Partners III L P | INSMED INC | 1,069,940 | 2.7% | EDGAR |
| SC 13D | 2013-06-10 | Prospect Venture Partners III L P | BAXANO SURGICAL, INC. | 5,340,616 | 11.8% | EDGAR |
| SC 13G | 2013-01-28 | Prospect Venture Partners III L P | KYTHERA BIOPHARMACEUTICALS INC | 1,914,566 | 10.5% | EDGAR |
| SC 13G | 2011-03-08 | Prospect Venture Partners III L P | INSMED INC | 1,604,940 | 7.0% | EDGAR |
| SC 13G | 2011-02-11 | Prospect Venture Partners III L P | COMPLETE GENOMICS INC | 3,180,255 | 12.2% | EDGAR |
| SC 13G/A | 2010-02-11 | Prospect Venture Partners III L P | Somaxon Pharmaceuticals, Inc. | 425,531 | 1.8% | EDGAR |
| SC 13G | 2009-07-17 | Prospect Venture Partners III L P | Somaxon Pharmaceuticals, Inc. | 1,717,168 | 7.2% | EDGAR |
| SC 13G/A | 2009-02-11 | Prospect Venture Partners III L P | NOVAVAX INC | 3,169,409 | 4.6% | EDGAR |
| SC 13D/A | 2008-02-14 | Prospect Venture Partners III L P | CRITICAL THERAPEUTICS INC | 798,358 | 1.8% | EDGAR |
| SC 13G/A | 2008-02-14 | Prospect Venture Partners III L P | Somaxon Pharmaceuticals, Inc. | 866,106 | 4.7% | EDGAR |
| SC 13G/A | 2008-02-14 | Prospect Venture Partners III L P | NOVAVAX INC | 3,116,637 | 5.0% | EDGAR |
| SC 13G | 2007-02-12 | Prospect Venture Partners III L P | NOVAVAX INC | - | 5.0% | EDGAR |
| SC 13G/A | 2006-02-15 | Prospect Venture Partners III L P | Somaxon Pharmaceuticals, Inc. | 1,167,226 | 6.5% | EDGAR |
| SC 13D | 2006-02-14 | Prospect Venture Partners III L P | CRITICAL THERAPEUTICS INC | 3,079,380 | 9.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.